selexipag
(Selexipag)Zydus Lifesciences Limited
Prostacyclin Receptor Agonists [MoA] class drugs
3 results
selexipag - selexipag tablet, film coated
(Selexipag)Zydus Pharmaceuticals (Usa) Inc.uptravi - selexipag tablet, coated
(Selexipag)Actelion Pharmaceuticals Us, Inc.Usage: Uptravi (selexipag) treats pulmonary arterial hypertension (PAH, WHO Group I) in adults to delay disease progression and reduce hospitalization risk. Studied in patients with WHO Functional Class II–III symptoms, including idiopathic, heritable, connective tissue disease-associated, and congenital heart disease-associated PAH.